| Product NDC: | 0004-0086 |
| Proprietary Name: | Copegus |
| Non Proprietary Name: | Ribavirin |
| Active Ingredient(s): | 200 mg/1 & nbsp; Ribavirin |
| Administration Route(s): | ORAL |
| Dosage Form(s): | TABLET, FILM COATED |
| Coding System: | National Drug Codes(NDC) |
| Product NDC: | 0004-0086 |
| Labeler Name: | Genentech, Inc. |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | NDA021511 |
| Marketing Category: | NDA |
| Start Marketing Date: | 20021203 |
| Package NDC: | 0004-0086-94 |
| Package Description: | 168 TABLET, FILM COATED in 1 BOTTLE, PLASTIC (0004-0086-94) |
| NDC Code | 0004-0086-94 |
| Proprietary Name | Copegus |
| Package Description | 168 TABLET, FILM COATED in 1 BOTTLE, PLASTIC (0004-0086-94) |
| Product NDC | 0004-0086 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | Ribavirin |
| Dosage Form Name | TABLET, FILM COATED |
| Route Name | ORAL |
| Start Marketing Date | 20021203 |
| Marketing Category Name | NDA |
| Labeler Name | Genentech, Inc. |
| Substance Name | RIBAVIRIN |
| Strength Number | 200 |
| Strength Unit | mg/1 |
| Pharmaceutical Classes | Nucleoside Analog [Chemical/Ingredient],Nucleoside Analog Antiviral [EPC] |